Senate health committee Chairman Lamar Alexander (R-TN) and ranking Democrat Patty Murray (D-WA) said the Senate doesn't have time to consider their committee’s cost-cutting package, which includes legislation to end surprise billing and lower drug prices, but they didn't say why. However, the decision comes as multiple senators still have holds on the surprise billing aspects of the legislation and the House and Senate versions of the bill are not in line. “We are engaged in very productive conversations about...